網頁

Monday, June 04, 2018

BIO 中國高峰會 葛延風談中國醫改藍圖(圖片)


BIO中國高峰會。(周菊子攝)

BIO執行副總裁Joseph Damond。(周菊子攝)

百華協會主席施晨陽致詞。(周菊子攝)


中國國務院發展研究中心部長葛延風。(周菊子攝)

中國國務院發展研究中心部長葛延風(左)接受BIO國際事務部
主任Monica He訪談。(周菊子攝)

Serica 合夥人執行合夥人Kewen Jin致詞。(周菊子攝)

第一場講座。(周菊子攝)

復星醫藥美國公司首席科學家毋麗君(左)和輝瑞製藥外
部研發執行總監丁元華都是波士頓華人。(周菊子攝)
晶泰科技首席科學觀蔣一得(左),輝瑞製藥外部科學創新執行總監
丁元華出席BIO中國生物高峰會。(周菊子攝)





















𝐂𝐡𝐢𝐧𝐚 𝐒𝐮𝐦𝐦𝐢𝐭 @ 𝐁𝐈𝐎 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥

生物技术创新协会(𝐁𝐈𝐎)国际生物技术展览大会 
中国高峰会

June 4, 2018 
11:45 AM to 5:00 PM ET

Join us to bridge innovation, enterprise and culture from Boston, one of the most distinguished biotechnology hubs in the world, to China, one of the largest pharmaceutical market in the world. The Summit will examine recent watersheds in China’s regulatory, policy, and industrial reforms positioned to create a globally competitive biopharmaceutical industry in China, as well as successful models for cross-border alliances and partnerships blazing a path toward biotech growth and innovation. 

𝐏𝐫𝐨𝐠𝐫𝐚𝐦
*𝘚𝘶𝘣𝘫𝘦𝘤𝘵 𝘵𝘰 𝘤𝘩𝘢𝘯𝘨𝘦; 𝘤𝘩𝘦𝘤𝘬 𝘵𝘩𝘦 𝘉𝘐𝘖 𝘊𝘰𝘯𝘷𝘦𝘯𝘵𝘪𝘰𝘯 𝘰𝘯𝘭𝘪𝘯𝘦 𝘥𝘦𝘴𝘤𝘳𝘪𝘱𝘵𝘪𝘰𝘯 𝘧𝘰𝘳 𝘭𝘢𝘵𝘦𝘴𝘵 𝘶𝘱𝘥𝘢𝘵𝘦𝘥 𝘢𝘨𝘦𝘯𝘥𝘢 

**𝘖𝘱𝘦𝘯 𝘵𝘰 𝘢𝘭𝘭 𝘢𝘵𝘵𝘦𝘯𝘥𝘦𝘦𝘴, 𝘪𝘯𝘤𝘭𝘶𝘥𝘪𝘯𝘨 𝘌𝘹𝘩𝘪𝘣𝘪𝘵𝘪𝘰𝘯 𝘈𝘤𝘤𝘦𝘴𝘴


The China Summit @ BIO International is a half-day program at the BIO International Convention to explore recent regulatory changes, investment trends, and cross-border collaborations in the life sciences sector. The gathering of industry leaders, experts and decision-makers will deliver a robust agenda featuring keynote presentations as well as panel debates on opportunities and challenges facing the biomedical industry in China. 

中国高峰会是在BIO 国际生物技术展览大会平台上的一个主题论坛,旨在探索与剖析中国医药界近期的体制改革,投资前景和跨境合作等等趋势展望。 本高峰会聚集了行业领导者及专家们组成一个多元化的会议议程,就中国生物医药行业面临的机遇和挑战展开小组讨论。 欢迎大家踊跃参加。


11:45 to 12:00pm - 𝐎𝐩𝐞𝐧 𝐒𝐞𝐚𝐭𝐢𝐧𝐠 𝐁𝐞𝐠𝐢𝐧𝐬

(Pick-up Box Lunches) 

12:00 to 12:25pm - 𝐎𝐩𝐞𝐧𝐢𝐧𝐠 𝐑𝐞𝐦𝐚𝐫𝐤𝐬

• Joe Damond, Executive VP for International Affairs, BIO
• Victor Shi, Chairman, Bayhelix Group; Founding President Asia Pacific QIAGEN

12:35 to 1:10pm - 𝐅𝐢𝐫𝐞𝐬𝐢𝐝𝐞 𝐂𝐡𝐚𝐭: 𝐁𝐥𝐮𝐞𝐩𝐫𝐢𝐧𝐭 𝐟𝐨𝐫 𝐂𝐡𝐢𝐧𝐚𝐬 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐑𝐞𝐟𝐨𝐫𝐦

• Director General GE Yanfeng, Social Development Research Division, Development Research Center of the State Council
• Moderator: Monica He, Director for International Affairs, BIO

1:15 to 2:10pm - 𝐊𝐞𝐲 𝐈𝐬𝐬𝐮𝐞𝐬 𝐓𝐨𝐝𝐚𝐲: 𝐑𝐞𝐠𝐮𝐥𝐚𝐭𝐨𝐫𝐲, 𝐈𝐏, 𝐚𝐧𝐝 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧

• Alan Turley, Deputy Assistant Secretary for China, U.S. Department of Commerce
• Tony Chen, Partner, Jones Day Shanghai
• Lijun Wu, Chief Scientific Officer, Fosun Pharma USA
• Yuan-Hua Ding, Executive Director and Head of External Science & Innovation, Pfizer
• Haishan Xiong, Senior VP for Business Development, Fountain Medical Development
• Moderator: Kewen Jin, Managing Partner, Serica Partners

2:15 to 3:30pm - 𝐍𝐞𝐰 𝐄𝐜𝐨𝐧𝐨𝐦𝐲 𝐋𝐢𝐟𝐞 𝐒𝐜𝐢𝐞𝐧𝐜𝐞𝐬 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐢𝐧𝐠 𝐆𝐥𝐨𝐛𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭𝐬


2:15-2:30pm - Presentation: Heading East: Biopharma International Expansion to China and Asia
• Helen Chen, Head of China and Asia Life Sciences, L.E.K. Consulting

2:30-3:30pm
• Edward Hu, Chief Financial Officer and Chief Investment Officer, WuXi AppTec
• Greg Scott, Founder and Chairman, ChinaBio Group
• Micah Mackison, Senior VP for Corporate Development and Strategy, Assembly Biosciences
• Jonathan Wang, Senior VP and Head of Business Development Zai Lab
• Donghui Qin, Director of Innovation, Ferring Pharmaceuticals
• Moderator: Helen Chen, Head of China and Asia Life Sciences, L.E.K. Consulting

3:35 to 4:45pm - 𝐓𝐫𝐞𝐧𝐝𝐬 𝐢𝐧 𝐅𝐢𝐧𝐚𝐧𝐜𝐢𝐧𝐠, 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 𝐌𝐚𝐫𝐤𝐞𝐭𝐬 𝐚𝐧𝐝 𝐂𝐫𝐨𝐬𝐬 𝐁𝐨𝐫𝐝𝐞𝐫 𝐁𝐃

• Michael Chan, Senior VP, HKEX 
• Katherine Andersen, Head of Healthcare Corporate Finance and East/Central Life Science, Silicon Valley Bank
• Wei Li, Founding Partner, 6 Dimensions Capital
• Wendy Pan, Partner, Sidley
• Alexandra Jung, Managing Director, EY-Parthenon
• Moderator: Debra Yu, Managing Director, China Renaissance Securities (US) Inc.

5:00 to 6:30pm - 𝐂𝐡𝐢𝐧𝐚 𝐕𝐈𝐏 𝐑𝐞𝐜𝐞𝐩𝐭𝐢𝐨𝐧 @ 𝐁𝐈𝐎 𝐈𝐧𝐭𝐞𝐫𝐧𝐚𝐭𝐢𝐨𝐧𝐚𝐥 (*Invitation Only*)

Location: Off-site